SBC Medical Group (SBC) to Release Earnings on Thursday

SBC Medical Group (NASDAQ:SBC) is expected to be posting its Q1 2026 results before the market opens on Thursday, May 14th. Analysts expect SBC Medical Group to post earnings of $0.10 per share and revenue of $41.6580 million for the quarter. Individuals are encouraged to explore the company’s upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Thursday, May 14, 2026 at 8:30 AM ET.

SBC Medical Group (NASDAQ:SBC) last announced its quarterly earnings data on Friday, March 27th. The company reported $0.14 earnings per share for the quarter, topping analysts’ consensus estimates of $0.13 by $0.01. SBC Medical Group had a net margin of 29.37% and a return on equity of 20.76%. The business had revenue of $39.57 million for the quarter, compared to analysts’ expectations of $45.19 million. On average, analysts expect SBC Medical Group to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

SBC Medical Group Trading Up 0.6%

NASDAQ:SBC opened at $3.22 on Thursday. The company’s 50 day moving average price is $3.86 and its 200-day moving average price is $3.97. SBC Medical Group has a 52 week low of $2.97 and a 52 week high of $5.75. The company has a quick ratio of 3.74, a current ratio of 3.78 and a debt-to-equity ratio of 0.13. The stock has a market cap of $330.31 million, a price-to-earnings ratio of 6.57 and a beta of 0.61.

Insiders Place Their Bets

In other SBC Medical Group news, CEO Yoshiyuki Aikawa sold 4,422,900 shares of the stock in a transaction that occurred on Friday, March 6th. The shares were sold at an average price of $2.12, for a total value of $9,376,548.00. Following the transaction, the chief executive officer directly owned 861,600 shares in the company, valued at approximately $1,826,592. This trade represents a 83.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders have sold 7,987,900 shares of company stock valued at $20,142,848 in the last 90 days. 89.47% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the business. Geode Capital Management LLC raised its position in SBC Medical Group by 37.6% in the fourth quarter. Geode Capital Management LLC now owns 262,043 shares of the company’s stock worth $1,129,000 after acquiring an additional 71,664 shares during the period. Millennium Management LLC bought a new position in SBC Medical Group in the third quarter worth approximately $219,000. Charles Schwab Investment Management Inc. raised its position in SBC Medical Group by 91.6% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 27,341 shares of the company’s stock worth $118,000 after acquiring an additional 13,074 shares during the period. New York State Common Retirement Fund bought a new position in SBC Medical Group in the second quarter worth approximately $104,000. Finally, Barclays PLC raised its position in SBC Medical Group by 123.7% in the fourth quarter. Barclays PLC now owns 17,779 shares of the company’s stock worth $77,000 after acquiring an additional 9,831 shares during the period. 60.82% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on SBC shares. BTIG Research started coverage on shares of SBC Medical Group in a report on Friday, March 6th. They set a “buy” rating and a $8.00 price target on the stock. Weiss Ratings reiterated a “sell (d+)” rating on shares of SBC Medical Group in a report on Friday, March 27th. Two research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $8.50.

SBC Medical Group Company Profile

SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company’s primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.